| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA2114854 | F | PubChem BioAssay. Late stage assay provider results from the probe development effort to identify inhibitors of pPAFAH: fluorescence-based dose-response biochemical gel-based competitive Activity-Based Protein Profiling (ABPP) assay for SAR compounds. (Class of assay: confirmatory) | Mus musculus | 5 | assay format | PubChem BioAssays | ||
| 2. | ALA2114765 | F | PubChem BioAssay. Late stage assay provider results from the probe development effort to identify inhibitors of plasma platelet activating factor acetylhydrolase (pPAFAH): fluorescence-based dose response biochemical gel-based competitive Activity-Based Protein Profiling (ABPP) inhibition of human pPAFAH. (Class of assay: confirmatory) | Homo sapiens | 1 | cell-free format | PubChem BioAssays | ||
| 3. | ALA3215171 | B | PubChem BioAssay. QFRET-based biochemical high throughput dose response assay to identify exosite inhibitors of ADAM17. (Class of assay: confirmatory) | 248 | single protein format | PubChem BioAssays | |||
| 4. | ALA3215228 | B | PubChem BioAssay. Counterscreen for exosite inhibitors of ADAM17: Fluorescence resonance energy transfer (FRET)-based biochemical high throughput dose response assay to identify inhibitors of ADAM10. (Class of assay: confirmatory) | 248 | assay format | PubChem BioAssays |
The page will load shortly, Thanks for your patience!